Projects per year
Fingerprint Dive into the research topics where Alex Adjei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 24 Similar Profiles
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Pemetrexed
Medicine & Life Sciences
gemcitabine
Medicine & Life Sciences
Lung Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Farnesyltranstransferase
Medicine & Life Sciences
irinotecan
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1976 2019
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
Project: Research project
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
Project: Research project
PHASE I CLINICAL TRIALS OF ANTICANCER AGENTS
Erlichman, C., Adjei, A. & Adjei, A.
6/1/95 → 2/28/14
Project: Research project
Clinical Trials, Phase I
Antineoplastic Agents
Pharmacokinetics
Pharmaceutical Preparations
Maximum Tolerated Dose
Research Output 1985 2019
1
Citation
(Scopus)
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study
Luo, Y. H., Luo, L., Wampfler, J. A., Wang, Y., Liu, D., Chen, Y. M., Adjei, A., Midthun, D. E. & Yang, P., Aug 1 2019, In : The Lancet Oncology. 20, 8, p. 1098-1108 11 p.Research output: Contribution to journal › Article
Open Access
Advisory Committees
Observational Studies
Lung Neoplasms
Cohort Studies
Survival
1
Citation
(Scopus)
Antibody-Drug Conjugates for the Therapy of Thoracic Malignancies
Xie, H. & Adjei, A., Mar 1 2019, In : Journal of Thoracic Oncology. 14, 3, p. 358-376 19 p.Research output: Contribution to journal › Review article
Thorax
Drug Therapy
Antibodies
Neoplasms
Pharmaceutical Preparations
A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma
Xie, H., Yin, J., Shah, M. H., Menefee, M. E., Bible, K. C., Reidy-Lagunes, D., Kane, M. A., Quinn, D. I., Gandara, D. R., Erlichman, C. & Adjei, A., Jan 1 2019, In : Investigational New Drugs.Research output: Contribution to journal › Article
Gossypol
Adrenocortical Carcinoma
Troponin
Hypokalemia
B-Cell Lymphoma
A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce
Friedberg, J. S., Culligan, M. J., Tsao, A. S., Rusch, V., Sepesi, B., Pass, H. I., Bueno, R., Burt, B., Sugarbaker, D. J., de Perrot, M., Adjei, A., Adusumilli, P. S., Hirsch, F. R., Malik, S. M. & Harpole, D. J., Aug 1 2019, In : Journal of Thoracic Oncology. 14, 8, p. 1343-1353 11 p.Research output: Contribution to journal › Review article
Joints
Mesothelioma
Lung
Research
Neoplasms
37
Citations
(Scopus)
Control of confounding and reporting of results in causal inference studies
Lederer, D. J., Bell, S. C., Branson, R. D., Chalmers, J. D., Marshall, R., Maslove, D. M., Ost, D. E., Punjabi, N. M., Schatz, M., Smyth, A. R., Stewart, P. W., Suissa, S., Adjei, A., Akdis, C. A., Azoulay, É., Bakker, J., Ballas, Z. K., Bardin, P. G., Barreiro, E., Bellomo, R. & 28 others, , Jan 1 2019, In : Annals of the American Thoracic Society. 16, 1, p. 22-28 7 p.Research output: Contribution to journal › Review article
Critical Care
Causality
Sleep
Epidemiology
Research Design